share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:拟议出售证券
美股sec公告 ·  06/06 10:41
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 06/06/2024, with an aggregate market value of $450,000. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 406,319 shares were sold for gross proceeds of approximately $3.77 million.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 06/06/2024, with an aggregate market value of $450,000. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 406,319 shares were sold for gross proceeds of approximately $3.77 million.
Recursion Pharmaceuticals, Inc.的官员兼董事Christopher Gibson计划于2024年06月06日出售50,000股A类股票,总市值为$450,000。这些股票最初是在2016年09月01日获得的创始股份,是发行人的一种补偿形式。这一计划销售是在过去三个月的一系列交易之后进行的,共售出406,319股股票,总收益约为$3.77百万美元。
Recursion Pharmaceuticals, Inc.的官员兼董事Christopher Gibson计划于2024年06月06日出售50,000股A类股票,总市值为$450,000。这些股票最初是在2016年09月01日获得的创始股份,是发行人的一种补偿形式。这一计划销售是在过去三个月的一系列交易之后进行的,共售出406,319股股票,总收益约为$3.77百万美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息